Literature DB >> 23949839

Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial.

Maryam Mousavi1, Alireza Hayatshahi, Amir Sarayani, Molouk Hadjibabaie, Mohammadreza Javadi, Hassan Torkamandi, Kheirollah Gholami, Ardeshir Ghavamzadeh.   

Abstract

PURPOSE: Parenteral nutrition (PN) is a well-documented supportive care which maintains the nutritional status of patients. Clinical pharmacists are often involved in providing PN services; however, few studies have investigated the effect of a clinical pharmacy-based PN service in resource-limited settings.
METHODS: We designed a randomized clinical trial to compare the clinical pharmacist-based PN service (intervention group) with the conventional method (control group) for adult patients undergoing hematopoietic stem cell transplantation in Shariati Hospital, Tehran, Iran (2011-2012). In the intervention group, the clinical pharmacists implemented standard guidelines of nutrition support. The conventional method was a routine nutrition support protocol which was pursued for all patients in the bone marrow transplantation wards. Main study outcomes included nutritional status (weight, albumin, total protein, pre-albumin, and nitrogen balance), length of hospital stay, time to engraftment, rate of graft versus host disease, and mortality rate. Patients were followed for 3 months.
RESULTS: Fifty-nine patients were randomly allocated to a study group. The overall intake (oral and parenteral) in the control group was significantly lower than standard daily needed calories (P < 0.01). Patients in the intervention group received fewer days of PN (10.7 ± 4.2 vs. 18.4 ± 5.5 days, P < 0.01). All nutritional outcomes were either preserved or improved in the intervention group while the nutritional status in the control group was deteriorated (P values < 0.01). Length of hospital stay was significantly shorter in the intervention group (P < 0.01). Regarding PN complications, hyperglycemia was observed more frequently in the intervention group (34.5 %, P = 0.01). Two patients in the control group expired due to graft versus host disease at the 3-month follow-up.
CONCLUSION: A clinical pharmacist-based nutrition support service significantly improved nutritional status and clinical outcomes in comparison with the suboptimal conventional method. Future studies should assess the cost effectiveness of clinical pharmacists' PN services.

Entities:  

Mesh:

Year:  2013        PMID: 23949839     DOI: 10.1007/s00520-013-1920-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  40 in total

Review 1.  Nutritional and metabolic support in patients undergoing bone marrow transplantation.

Authors:  Maurizio Muscaritoli; Gabriella Grieco; Saveria Capria; Anna Paola Iori; Filippo Rossi Fanelli
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

2.  Safe practices for parenteral nutrition.

Authors:  Jay Mirtallo; Todd Canada; Deborah Johnson; Vanessa Kumpf; Craig Petersen; Gordon Sacks; David Seres; Peggi Guenter
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

3.  Pharmaceutical interventions in metabolic and nutritional follow-up of surgical patients receiving parenteral nutrition.

Authors:  J Llop-Talaverón; B Gracia-García; J J Machí-Ribes; M Perayre-Badia; M B Badia-Tahull; R Jódar-Masanes
Journal:  Farm Hosp       Date:  2008 Jul-Aug

Review 4.  Impact of nutrition on quality of life during cancer.

Authors:  Mónica María Marín Caro; Alessandro Laviano; Claude Pichard
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-07       Impact factor: 4.294

5.  Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation.

Authors:  Patricia M Sheean; Sally A Freels; W Scott Helton; Carol A Braunschweig
Journal:  Biol Blood Marrow Transplant       Date:  2006-06       Impact factor: 5.742

Review 6.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

7.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

8.  Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay.

Authors:  P Horsley; J Bauer; B Gallagher
Journal:  Bone Marrow Transplant       Date:  2005-06       Impact factor: 5.483

9.  The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: a pilot study.

Authors:  Patricia M Sheean; Carol Braunschweig; Elizabeth Rich
Journal:  J Am Diet Assoc       Date:  2004-09

10.  Serum electrolyte changes at engraftment time in patients undergoing allogeneichematopoietic stem cell transplantation.

Authors:  Toktam Faghihi; Masoud Iravani; Ahmad Reza Shamshiri; Molouk Hadjibabaie; Seyyed Asadolah Mousavi; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Ann Transplant       Date:  2009 Jul-Sep       Impact factor: 1.530

View more
  8 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

2.  Challenges and outcomes of a randomized study of early nutrition support during autologous stem-cell transplantation.

Authors:  N Kiss; J F Seymour; H M Prince; G Dutu
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

3.  Nutritional assessment as predictor of complications after hematopoietic stem cell transplantation.

Authors:  Marcela Espinoza; Javiera Perelli; Roberto Olmos; Pablo Bertin; Verónica Jara; Pablo Ramírez
Journal:  Rev Bras Hematol Hemoter       Date:  2015-11-27

Review 4.  Role of pharmacists in providing parenteral nutrition support: current insights and future directions.

Authors:  Maram Gamal Katoue
Journal:  Integr Pharm Res Pract       Date:  2018-10-02

5.  Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients.

Authors:  K J Skaarud; M B Veierød; S Lergenmuller; A Bye; P O Iversen; G E Tjønnfjord
Journal:  Bone Marrow Transplant       Date:  2019-08-27       Impact factor: 5.483

6.  Examination of a nutritional treatment pathway according to pretreatment health status and stress levels of patients undergoing hematopoietic stem cell transplantation.

Authors:  Takashi Aoyama; Osamu Imataki; Akifumi Notsu; Takashi Yurikusa; Koki Ichimaru; Masanori Tsuji; Kanako Yoshitsugu; Masafumi Fukaya; Terukazu Enami; Takashi Ikeda
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

7.  Role of the pharmacist in parenteral nutrition therapy: challenges and opportunities to implement pharmaceutical care in Kuwait.

Authors:  Maram G Katoue; Dalal Al-Taweel
Journal:  Pharm Pract (Granada)       Date:  2016-06-15

8.  Benefit of Reducing Body Weight Loss with A Nutritional Support Pathway in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Takashi Aoyama; Kanako Yoshitsugu; Masafumi Fukaya; Tetsuo Kume; Miho Kawashima; Kazuko Nakajima; Hidekazu Arai; Osamu Imataki; Terukazu Enami; Raine Tatara; Takashi Ikeda
Journal:  Med Sci Monit Basic Res       Date:  2019-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.